ABOS
Acumen Pharmaceuticals, Inc.
$2.57
-0.10 (-3.75%)
At close · Jul 7
Market Cap
$196.10M
Shares
72,227,580
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$121.34M
-18.6%
FY2025
Diluted EPS
-$2.00
-17%
FY2025
Operating Cash Flow
-$115.54M
-34%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| $96.1M | $104.89M | $93.8M | $42.32M | $32.36M | $12.31M | |
| $18.51M | $18.95M | $20.22M | $18.82M | $12.88M | $7.28M | |
| $114.61M | $123.83M | $114.02M | $61.14M | $45.24M | $19.58M | |
| -$114.61M | -$123.83M | -$114.02M | -$61.14M | -$45.24M | -$19.58M | |
| $4.27M | $4.22M | $4.07M | $581K | — | — | |
| $6.04M | $7.45M | $14.32M | — | — | — | |
| $1.34M | $2.5M | $11.69M | $8.77M | $2.38M | -$81.02M | |
| — | $0 | $0 | $0 | $0 | $0 | |
| -$113.28M | -$121.34M | -$102.33M | -$52.37M | -$42.86M | -$100.61M | |
| -$113.27M | -$121.2M | -$102.69M | -$51.31M | -$43.38M | — | |
| USD/shares | — | -$2.00 | -$1.71 | -$1.08 | -$1.06 | — |
| USD/shares | — | -$2.00 | -$1.71 | -$1.08 | -$1.06 | — |
| shares | — | 60.56M | 60.01M | 48.61M | 40.6M | 20.06M |
| shares | — | 60.56M | 60.01M | 48.61M | 40.6M | 20.06M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.